发明名称 RNAi-mediated inhibition of ocular targets
摘要 RNA interference is provided for inhibition of ocular hypertension target mRNA expression for lowering elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Ocular hypertension targets include carbonic anhydrase II, IV, and XII; beta1- and beta2 adrenergic receptors; acetylcholinesterase; Na+/K+-ATPase; and Na-K-2Cl cotransporter. Ocular hypertension is treated by administering interfering RNAs of the present invention.
申请公布号 US7592324(B2) 申请公布日期 2009.09.22
申请号 US20060345361 申请日期 2006.02.01
申请人 ALCON, INC. 发明人 SHEPARD ALLAN R.;CHATTERTON JON E.;CLARK ABBOT F.;WAX MARTIN B.
分类号 A61K31/70;C07H21/02;C07H21/04;C12N5/00;C12N15/113;C12Q1/68 主分类号 A61K31/70
代理机构 代理人
主权项
地址
您可能感兴趣的专利